Table 1 Comparison of clinical and laboratory variables between survivors and non-survivors with ALF.
Variables | Survivors (391) Mean ± SD/median (IQR) | Non-survivors (249) Mean ± SD/median (IQR) | p value |
|---|---|---|---|
Age (years) | 57 (43–69) | 53 (43–68) | 0.38 |
Male sex, n (%) | 204 (52.17) | 148 (59.44) | 0.072 |
ICU length of stay (days) | 12.19 ± 15.99 | 7.15 ± 6.30 | < 0.001 |
SOFA | 7.05 ± 3.75 | 8.70 ± 4.04 | < 0.001 |
King’s College criteria (KCC) | 1.00 (0.00–1.00) | 1.00 (0.00–1.50) | < 0.001 |
Alanine aminotransferase (U/L) | 2082 ± 3187 | 1344 ± 2031 | 0.003 |
Aspartate transaminase (U/L) | 2741 ± 4081 | 2293 ± 3237 | 0.180 |
Alkaline phosphatase (U/L) | 104 (71–161) | 124 (82–178) | 0.007 |
Bilirubin (mg/dL) | 2.00 (0.90–5.45) | 2.80 (1.00–8.90) | 0.016 |
Albumin (g/dL) | 3.04 ± 0.65 | 2.80 ± 0.54 | < 0.001 |
INR | 2.66 ± 2.47 | 2.83 ± 2.47 | 0.411 |
Urea (mg/dL) | 37.80 ± 28.94 | 43.12 ± 27.76 | 0.022 |
Creatinine (mg/dL) | 2.21 ± 1.83 | 2.46 ± 1.91 | 0.093 |
Sodium (mEq/L) | 139.99 ± 5.43 | 140.10 ± 5.94 | 0.811 |
Chloride (mEq/L) | 107.28 ± 7.04 | 106.07 ± 7.29 | 0.038 |
Phosphate (mg/dL) | 4.37 ± 2.44 | 5.33 ± 2.24 | < 0.001 |
Bicarbonate (mEq/L) | 22.55 ± 4.70 | 22.36 ± 5.18 | 0.984 |
Lactate (mmol/L) | 3.10 (1.90–5.55) | 5.05 (2.80–8.80) | < 0.001 |
Arterial blood pH | 7.42 ± 0.07 | 7.39 ± 0.11 | 0.004 |
Glucose (mg/dL) | 177.36 ± 80.81 | 202.65 ± 105.80 | 0.001 |
Haemoglobin (mg/dL) | 11.65 ± 2.15 | 11.32 ± 2.13 | 0.058 |
Platelet count (x 1000/µl) | 198 ± 118 | 180 ± 108 | 0.061 |
White blood count (x 1000/µl) | 14.31 ± 9.33 | 14.86 ± 8.10 | 0.453 |
Temperature (°C) | 36.88 ± 1.22 | 36.69 ± 1.63 | 0.089 |
Heart rate (beat/min) | 94 ± 18 | 95 ± 18 | 0.522 |
Mean blood pressure (mmHg) | 81.07 ± 12.00 | 78.02 ± 11.95 | 0.002 |
Respiratory rate (breath/min) | 20.55 ± 4.97 | 21.24 ± 4.92 | 0.084 |
SpO2 (%) | 96.74 ± 2.97 | 95.84 ± 4.71 | 0.003 |
Glasgow coma score (GCS) | 9.27 ± 5.11 | 7.62 ± 4.81 | < 0.001 |